In a preliminary analysis of the correlation of DDR2 expression and 42-mesenchymal metabolism enzymes across TCGA breast cancer samples, we found a robust positive correlation (R = 0.84, Spearman; Fig. 7A). Here, DDR2 is linked to breast carcinoma.